Serina Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Serina Therapeutics (SER).

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$11Upside to Avg. PT+586.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 26, 2026	BTIG	Thomas Shrader	Maintained	Buy	$8
Sep 10, 2026	BTIG	Thomas Shrader	Maintained	Buy	$8
Jul 1, 2026	BTIG	Thomas Shrader	Initiate	Buy	$8
Aug 28, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$15
Jul 14, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$15
Mar 11, 2025	Jones Trading	Justin Walsh	Initiate	Buy	$11

Analyst Ratings News

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

BTIG analyst Thomas Shrader reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

BTIG analyst Thomas Shrader initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Serina Therapeutics, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Serina Therapeutics (AMEX:SER) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $15

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Serina Therapeutics (AMEX:SER) with a Buy rating and announces Price Target of $15.

Benzinga Newsdesk

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Serina Therapeutics Inc

Serina Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PRO
BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

PRO
HC Wainwright & Co. Reiterates Buy on Serina Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $15

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

Serina Therapeutics Inc

Serina Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PROBTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PROBTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

PROHC Wainwright & Co. Reiterates Buy on Serina Therapeutics, Maintains $15 Price Target

PROHC Wainwright & Co. Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $15

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PRO
BTIG Reiterates Buy on Serina Therapeutics, Maintains $8 Price Target

PRO
BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8

PRO
HC Wainwright & Co. Reiterates Buy on Serina Therapeutics, Maintains $15 Price Target

PRO
HC Wainwright & Co. Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $15